Xylem (XYL) 10-Q 29 Apr 14 2014 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2014	Apr. 25, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'Xylem Inc.	'
Entity Central Index Key	'0001524472	'
Document Type	'10-Q	'
Document Period End Date	31-Mar-14	'
Amendment Flag	'false	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	183,777,788

Condensed_Consolidated_and_Com

Condensed Consolidated and Combined Income Statements (Unaudited) (USD $)	3 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Income Statement [Abstract]	'	'
Revenue	$906	$879
Cost of revenue	564	545
Gross profit	342	334
Selling, general and administrative expenses	224	237
Research and development expenses	27	26
Restructuring charges	15	5
Operating income	76	66
Interest expense	14	13
Other non-operating (expense) income, net	-1	-2
Income before taxes	61	51
Income tax expense	12	10
Net income	$49	$41
Earnings per share:	'	'
Basic (usd per share)	$0.27	$0.22
Diluted (usd per share)	$0.27	$0.22
Weighted average number of shares:	'	'
Basic (in shares)	184,547	185,807
Diluted (in shares)	185,769	186,435
Dividends declared per share (usd per share)	$0.13	$0.12

Condensed_Consolidated_and_Com1

Condensed Consolidated and Combined Statements of Comprehensive Income (Unaudited) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Statement of Comprehensive Income [Abstract]	'	'
Net income	$49	$41
Other comprehensive income, before tax:	'	'
Foreign currency translation adjustment	-2	-43
Net change in cash flow hedges:	'	'
Unrealized (losses) gains	-1	-2
Amount of gain reclassified into net income	0	-1
Net change in postretirement benefit plans:	'	'
Amortization of net actuarial loss	3	4
Other comprehensive (loss) income, before tax	0	-42
Income tax expense related to items of other comprehensive income	1	1
Other comprehensive (loss) income, net of tax	-1	-43
Comprehensive (loss) income	$48	($2)

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$466	$533
Receivables, less allowances for discounts and doubtful accounts of $25 and $31 in 2014 and 2013, respectively	803	817
Inventories, net	516	475
Prepaid and other current assets	166	143
Deferred income tax assets	40	41
Total current assets	1,991	2,009
Property, plant and equipment, net	476	488
Goodwill	1,719	1,718
Other intangible assets, net	480	488
Other non-current assets	221	193
Total assets	4,887	4,896
Current liabilities:	'	'
Accounts payable	325	332
Accrued and other current liabilities	488	479
Short-term borrowings and current maturities of long-term debt	44	42
Total current liabilities	857	853
Long-term debt	1,199	1,199
Accrued postretirement benefits	348	348
Deferred income tax liabilities	198	191
Other non-current accrued liabilities	56	64
Total liabilities	2,658	2,655
Commitments and contingencies (Note 17)	'	'
Stockholders’ equity:	'	'
Authorized 750.0 shares, issued 188.2 shares and 187.6 shares in 2014 and 2013, respectively	2	2
Capital in excess of par value	1,768	1,753
Retained earnings	430	405
Treasury stock – at cost 4.4 shares and 3.0 shares in 2014 and 2013, respectively	-137	-86
Accumulated other comprehensive income	166	167
Total stockholders’ equity	2,229	2,241
Total liabilities and stockholders’ equity	$4,887	$4,896

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Millions, except Per Share data, unless otherwise specified
Statement of Financial Position [Abstract]	'	'
Allowances for discounts and doubtful accounts on receivables	$25	$31
Common Stock, par value	$0.01	$0.01
Common Stock, shares authorized	750	750
Common Stock, shares issued	188.2	187.6
Treasury Stock, shares	4.4	3

Condensed_Consolidated_and_Com2

Condensed Consolidated and Combined Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Operating Activities	'	'
Net income	$49	$41
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation	23	25
Amortization	13	12
Share-based compensation	4	6
Restructuring charges	15	5
Other, net	4	0
Payments for restructuring	-9	-4
Changes in assets and liabilities (net of acquisitions):	'	'
Changes in receivables	-5	1
Changes in inventories	-42	-29
Changes in accounts payable	-2	-8
Other, net	-28	-29
Net Cash – Operating activities	22	20
Investing Activities	'	'
Capital expenditures	-25	-30
Acquisitions of businesses and assets, net of cash acquired	0	-78
Proceeds from the sale of property, plant and equipment	1	3
Net Cash – Investing activities	-24	-105
Financing Activities	'	'
Issuance of short-term debt	2	0
Repurchase of common stock	-51	-15
Proceeds from exercise of employee stock options	11	0
Dividends paid	-24	-22
Excess tax benefit from share based compensation	1	0
Other, net	-1	1
Net Cash – Financing activities	-62	-36
Effect of exchange rate changes on cash	-3	-8
Net change in cash and cash equivalents	-67	-129
Cash and cash equivalents at beginning of year	533	'
Cash and cash equivalents at end of period	466	375
Cash paid during the period for:	'	'
Interest	11	11
Income taxes (net of refunds received)	$18	$27

Background_and_Basis_of_Presen

Background and Basis of Presentation	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Background and Basis of Presentation	'
	Background and Basis of Presentation
	Background
	Xylem Inc. ("Xylem" or the "Company") is a leading equipment and service provider for water and wastewater applications with a broad portfolio of products and services addressing the full cycle of water, from collection, distribution and use to the return of water to the environment. Xylem was incorporated in Indiana on May 4, 2011.
	Xylem operates in two segments, Water Infrastructure and Applied Water. The Water Infrastructure segment focuses on the transportation, treatment and testing of water, offering a range of products including water and wastewater pumps, treatment and testing equipment, and controls and systems. The Applied Water segment serves many of the primary uses of water and focuses on the residential, commercial, industrial and agricultural markets. The Applied Water segment’s major products include pumps, valves, heat exchangers, controls and dispensing equipment.
	Hereinafter, except as otherwise indicated or unless the context otherwise requires, "Xylem," "we," "us," "our" and the "Company" refer to Xylem Inc. and its subsidiaries.
	Basis of Presentation
	The interim condensed consolidated financial statements reflect our financial position and results of operations in conformity with accounting principles generally accepted in the United States of America ("GAAP"). All transactions between our businesses have been eliminated.
	The unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and, in the opinion of management, reflect all adjustments (which include normal recurring adjustments) considered necessary for a fair presentation of the financial position and results of operations for the periods presented. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such SEC rules. We believe that the disclosures made are adequate to make the information presented not misleading. We consistently applied the accounting policies described in our Annual Report on Form 10-K for the year ended December 31, 2013 ("2013 Annual Report") in preparing these unaudited condensed consolidated financial statements, with the exception of accounting standard updates described in Note 2. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in our 2013 Annual Report. Certain prior year amounts have been reclassified to conform to the current year presentation.
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Estimates are revised as additional information becomes available. Estimates and assumptions are used for, but not limited to, postretirement obligations and assets, revenue recognition, income tax contingency accruals and valuation allowances, goodwill impairment testing and contingent liabilities. Actual results could differ from these estimates. Additionally, our interim condensed consolidated financial statements may not be indicative of our future performance.
	Our quarterly financial periods end on the Saturday closest to the last day of the calendar quarter, except for the fourth quarter which ends on December 31. For ease of presentation, the condensed consolidated financial statements included herein are described as ending on the last day of the calendar quarter.

Recently_Issued_Accounting_Pro

Recently Issued Accounting Pronouncements	3 Months Ended
	Mar. 31, 2014
Accounting Changes and Error Corrections [Abstract]	'
Recently Issued Accounting Pronouncements	'
	Recently Issued Accounting Pronouncements
	Pronouncements Not Yet Adopted
	In April 2014, the Financial Accounting Standards Board (“FASB”) issued guidance related to the reporting of discontinued operations. The guidance states that the disposal of a business or operation is required to be reported as discontinued operations if the disposal represents a strategic shift that will have a major effect on an entity’s operations and financial results. The guidance also expands disclosures about discontinued operations and the disposal of significant businesses that did not qualify for discontinued operations presentation. This standard is effective for disposals (or businesses that qualify as “held for sale”) that occur within annual periods beginning on or after December 15, 2014 and interim periods within those years. The impact of this guidance on our financial condition and results of operations will depend on the occurrence and the significance of disposal transactions that meet the criteria described above.
	In January 2014, the FASB issued guidance related to service concession arrangements. A service concession arrangement is an arrangement between a public-sector entity grantor and an operating entity under which the operating entity operates the grantor's infrastructure (for example, airports, roads and bridges). The guidance states that service concession arrangements should not be accounted for under the guidance of Topic 840, Leases, but rather other guidance as deemed appropriate. This guidance is effective for fiscal years beginning on or after December 15, 2014. We are currently evaluating the impact of the guidance on our financial condition and results of operations.
	Recently Adopted Pronouncements
	In July 2013, the FASB issued guidance on the financial statement presentation of an unrecognized tax benefit. The guidance requires that an unrecognized tax benefit or a portion of an unrecognized tax benefit, be presented as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. If an applicable deferred tax asset is not available or a company does not expect to use the applicable deferred tax asset, the unrecognized tax benefit should be presented in an entity's financial statements as a liability and should not be combined with a deferred tax asset. This guidance is effective for fiscal years beginning after December 15, 2013. The adoption of this guidance did not have a material impact on our financial condition or results of operations.
	In March 2013, the FASB issued guidance on the release of a cumulative translation adjustment ("CTA") related to an entity's investment in a foreign entity into income. The guidance requires such CTA to be released when there has been a: (1) sale of a subsidiary or group of net assets within a foreign entity and the sale represents the substantially complete liquidation of the investment in the foreign entity, (2) loss of a controlling financial interest in an investment in a foreign entity or (3) step acquisition for a foreign entity. This guidance is effective for fiscal years beginning after December 15, 2013. The impact of the guidance on our financial condition and results of operations will depend on the occurrence and the significance of transactions that meet the criteria described above.
	In February 2013, the FASB issued guidance related to the measurement and disclosure of obligations resulting from joint and several liability arrangements. The new guidance requires companies to measure obligations resulting from joint and several liability arrangements as the sum of (1) the amount the company agreed to pay on the basis of its arrangement among co-obligors and (2) any additional amount the company expects to pay on behalf of its co-obligors. Additionally, the new guidance requires the disclosure of a description of the joint and several arrangement and the total outstanding amount of the obligation for all joint parties. This guidance is effective for fiscal years beginning after December 15, 2013. The adoption of this guidance did not have a material impact on our financial condition or results of operations.

Acquisitions

Acquisitions	3 Months Ended
	Mar. 31, 2014
Business Combinations [Abstract]	'
Acquisitions	'
	Acquisitions
	During the three months ended March 31, 2013, we spent $81 million ($78 million, net of cash acquired) on two acquisitions that were not material individually or in the aggregate to our results of operations or financial position.

Restructuring_Charges

Restructuring Charges	3 Months Ended
	Mar. 31, 2014
Restructuring and Related Activities [Abstract]	'
Restructuring, Impairment, and Other Activities Disclosure	'
	Restructuring Charges
	During the three months ended March 31, 2014, we recognized restructuring charges of $15 million. We incurred these charges primarily in an effort to reposition our European and North American business to optimize our cost structure and improve our operational efficiency and effectiveness. The charges relate to the reduction in structural costs, including the elimination of headcount and consolidation of facilities within both our Water Infrastructure and Applied Water segments. During the three months ended March 31, 2013 we recognized restructuring charges of $5 million. These charges related to the reduction in structural costs, including the consolidation of facilities, within our Water Infrastructure segment.
	The following table presents the components of restructuring expense for the three months ended March 31, 2014 and 2013.
		Three Months Ended
		March 31,
	(in millions)	2014				2013
	By component:
	Severance and other charges	$	15			$	5
	Reversal of restructuring accruals	—				—
	Total restructuring charges	$	15			$	5
	By segment:
	Water Infrastructure	$	10			$	5
	Applied Water	5				—
	Corporate and other	—				—
	The following table displays a rollforward of the restructuring accruals, presented on our Condensed Consolidated Balance Sheets within accrued and other current liabilities, for the three months ended March 31, 2014 and 2013.
	(in millions)		2014				2013
	Restructuring accruals - January 1		$	13			$	9
	Restructuring charges		15				5
	Cash payments		(9		)		(4		)
	Restructuring accruals - March 31		$	19			$	10
	By segment:
	Water Infrastructure		$	14			$	7
	Applied Water		5				3
	Corporate and other		—				—
	The following is a rollforward of employee position eliminations associated with restructuring activities for the three months ended March 31, 2014 and 2013.
			2014			2013
	Planned reductions - January 1		51			54
	Additional planned reductions		170			99
	Actual reductions		(109	)		(52	)
	Planned reductions - March 31		112			101
	Total expected costs associated with actions that commenced during the three months ended March 31, 2014 are approximately $10 million for Water Infrastructure and approximately $7 million for Applied Water. These costs primarily comprise severance charges. Related to these actions we incurred approximately $9 million for Water Infrastructure and approximately $5 million for Applied Water during the three months ended March 31, 2014. We currently expect these actions to continue through the third quarter of 2014.
	Total expected costs associated with actions that commenced during 2013 are approximately $33 million for Water Infrastructure. Approximately $31 million of the expected cost was incurred in 2013, $1 million was incurred during the three months ended March 31, 2014, and $1 million is expected to be incurred through the end of 2014. Total expected costs associated with actions that commenced during 2013 are approximately $10 million for Applied Water. Approximately $8 million of the expected cost was incurred in 2013 and $2 million is expected to be incurred through the end of 2014.

Income_Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Income Taxes
	Our quarterly provision for income taxes is measured using an estimated annual effective tax rate, adjusted for discrete items within periods presented. The comparison of our effective tax rate between periods is significantly impacted by the level and mix of earnings and losses by tax jurisdiction, foreign income tax rate differentials and amount of permanent book-to-tax differences.
	The income tax provision for the three months ended March 31, 2014 was $12 million at an effective tax rate of 19.1%, compared to $10 million at an effective tax rate of 19.1% for the same period in 2013. The effective tax rate was lower than the statutory rate in each period primarily due to geographic mix of earnings.
	Unrecognized Tax Benefits
	We recognize tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized from such positions are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.
	The amount of unrecognized tax benefits at March 31, 2014 was $30 million which, if ultimately recognized, will reduce our annual effective tax rate. We do not believe that the unrecognized tax benefits will significantly change within the next twelve months.
	We classify interest expense relating to unrecognized tax benefits as a component of other non-operating expense, net and tax penalties as a component of income tax expense in our Condensed Consolidated Income Statements. As of March 31, 2014, we had $1 million of interest accrued for unrecognized tax benefits.

Earnings_Per_Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share	'
	Earnings Per Share
	The following is a reconciliation of the shares used in calculating basic and diluted net earnings per share.
		Three Months Ended
		March 31,
		2014			2013
	Net income (in millions)	$	49		$	41
	Shares (in thousands):
	Weighted average common shares outstanding	184,505			185,573
	Add: Participating securities (a)	42			234
	Weighted average common shares outstanding — Basic	184,547			185,807
	Plus incremental shares from assumed conversions: (b)
	Dilutive effect of stock options	659			178
	Dilutive effect of restricted stock	563			450
	Weighted average common shares outstanding — Diluted	185,769			186,435
	Basic earnings per share	$	0.27		$	0.22
	Diluted earnings per share	$	0.27		$	0.22
	(a)	Restricted stock awards containing rights to non-forfeitable dividends that participate in undistributed earnings with common shareholders are considered participating securities for purposes of computing earnings per share.
	(b)	Incremental shares from stock options, restricted stock and performance share units are computed by the treasury stock method. The weighted average shares listed below were not included in the computation of diluted earnings per share because to do so would have been anti-dilutive for the periods presented or were otherwise excluded under the treasury stock method. The treasury stock method calculates dilution assuming the exercise of all in-the-money options and vesting of restricted stock and performance share awards, reduced by the repurchase of shares with the proceeds from the assumed exercises, unrecognized compensation expense for outstanding awards and the estimated tax benefit of the assumed exercises. Performance share units will be included in the treasury stock calculation of diluted earnings per share upon achievement of underlying performance conditions. See Note 14, "Stock-Based Compensation Plans" for further detail on the performance share units.
		Three Months Ended
		March 31,
	(in thousands)	2014		2013
	Stock options	2,746		4,130
	Restricted stock	449		757
	Performance shares	69		40

Inventories

Inventories	3 Months Ended
	Mar. 31, 2014
Inventory Disclosure [Abstract]	'
Inventories	'
	Inventories
	(in millions)	March 31,		December 31,
		2014		2013
	Finished goods	$	212	$	189
	Work in process	35		31
	Raw materials	269		255
	Total inventories, net	$	516	$	475

Property_Plant_and_Equipment

Property, Plant and Equipment	3 Months Ended
	Mar. 31, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment	'
	Property, Plant and Equipment
	(in millions)	March 31,		December 31,
		2014		2013
	Land, buildings and improvements	$	256	$	263
	Machinery and equipment	686		685
	Equipment held for lease or rental	197		192
	Furniture and fixtures	94		93
	Construction work in progress	50		49
	Other	22		22
	Total property, plant and equipment, gross	1,305		1,304
	Less accumulated depreciation	829		816
	Total property, plant and equipment, net	$	476	$	488
	Depreciation expense of $23 million and $25 million was recognized in the three months ended March 31, 2014 and 2013, respectively.

Goodwill_and_Other_Intangible_

Goodwill and Other Intangible Assets	3 Months Ended
	Mar. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill and Other Intangible Assets	'
	Goodwill and Other Intangible Assets
	Changes in the carrying value of goodwill by reportable segment for the three months ended March 31, 2014 are as follows:
	(in millions)	Water		Applied Water			Total
		Infrastructure
	Balance as of January 1, 2014	$	1,149	$	569		$	1,718
	Activity in 2014
	Foreign currency and other	2		(1		)	1
	Balance as of March 31, 2014	$	1,151	$	568		$	1,719
	Based on the results of our latest annual impairment tests, we determined that no impairment of goodwill existed as of the measurement date in 2013. However, future goodwill impairment tests could result in a charge to earnings. We will continue to evaluate goodwill on an annual basis as of the beginning of our fourth quarter and whenever events and changes in circumstances indicate there may be a potential impairment.
	Other Intangible Assets
	Information regarding our other intangible assets is as follows:
		31-Mar-14							December 31, 2013
	(in millions)	Carrying		Accumulated			Net		Carrying		Accumulated			Net
		Amount		Amortization			Intangibles		Amount		Amortization			Intangibles
	Customer and distributor relationships	$	350	$	(109	)	$	241	$	352	$	(104	)	$	248
	Proprietary technology	109		(38		)	71		109		(36		)	73
	Trademarks	35		(16		)	19		35		(16		)	19
	Patents and other	23		(19		)	4		20		(17		)	3
	Indefinite-lived intangibles	145		—			145		145		—			145
		$	662	$	(182	)	$	480	$	661	$	(173	)	$	488
	Based on the results of our most recent annual impairment tests, we recorded a $2 million charge related to three trade names within our Water Infrastructure segment in the fourth quarter 2013. As of March 31, 2014, no events or circumstances have occurred that indicate an additional impairment has occurred. We will continue to monitor the indefinite-lived intangible assets on an annual basis as of the beginning of our fourth quarter and whenever events and changes in circumstances indicate there may be a potential impairment.
	Amortization expense related to finite-lived intangible assets was $9 million for both the three months ended March 31, 2014 and 2013.

Derivative_Financial_Instrumen

Derivative Financial Instruments	3 Months Ended
	Mar. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Derivative Financial Instruments	'
	Derivative Financial Instruments
	Risk Management Objective of Using Derivatives
	We are exposed to certain risks arising from both our business operations and economic conditions and principally manage our exposures to these risks through management of our core business activities. Certain of our foreign operations expose us to fluctuations of foreign interest rates and exchange rates that may impact revenues, expenses, cash receipts and payments. We enter into derivative financial instruments to protect the value or fix the amount of certain cash flows in terms of the functional currency of the business unit with that exposure.
	Cash Flow Hedges of Foreign Exchange Risk
	We are exposed to fluctuations in various foreign currencies against our functional currencies. We use foreign currency derivatives including currency forward agreements to manage our exposure to fluctuations in the various exchange rates. Currency forward agreements involve fixing the foreign currency exchange rate for delivery of a specified amount of foreign currency on a specified date.
	Certain business units within our segments with exposure to foreign currency exchange risks have designated certain currency forward agreements as cash flow hedges of forecasted intercompany inventory purchases and sales.
	Listed in the table below are the outstanding foreign currency derivatives that were used to hedge foreign exchange risks as of March 31, 2014.
	(in millions; except number of instruments)
	Foreign Currency Derivative		Number of		Total Notional			Sell Notional Currency	Total Notional	Buy Notional
			Instruments		Sold				Purchased	Currency
	Buy HUF/Sell EUR forward		8		8			Euro (EUR)	2,410	Hungarian Forint (HUF)
	Buy PLN/ Sell EUR forward		16		19			Euro (EUR)	78	Polish Zloty (PLN)
	Buy SEK/Sell EUR forward		8		100			Euro (EUR)	903	Swedish Krona (SEK)
	Sell AUD/Buy EUR Forward		16		20			Australian Dollar (AUD)	13	Euro (EUR)
	Sell AUD/Buy USD Forward		7		6			Australian Dollar (AUD)	6	United States Dollar (USD)
	Sell GBP/Buy EUR forward		21		33			British Pound Sterling (GBP)	40	Euro (EUR)
	Sell USD/Buy EUR Forward		36		105			United States Dollar (USD)	76	Euro (EUR)
	The table below presents the effect of our derivative financial instruments on the Condensed Consolidated Income Statements and Statements of Comprehensive Income.
		Three Months Ended
		March 31,
	(in millions)	2014			2013
	Derivatives in Cash Flow Hedges
	Foreign Exchange Contracts
	Amount of gain (loss) recognized in Other Comprehensive Income (a)	$	(1	)	$	(2	)
	Amount of (gain) loss reclassified from Other Comprehensive Income into revenue (a)	(1		)	(1		)
	Amount of (gain) loss reclassified from Other Comprehensive Income into cost of revenue (a)	1			—
	(a)	Effective portion
	As of March 31, 2014, $1 million of the net unrealized gains on cash flow hedges is expected to be reclassified into earnings in the next 12 months. The ineffective portion of the change in fair value of a cash flow hedge is excluded from effectiveness testing and is recognized immediately in selling, general and administrative expenses in the Condensed Consolidated Income Statements. For the three months ended March 31, 2014 and 2013, the amounts were not material.
	The fair values of our foreign exchange contracts currently included in our hedging program were as follows:
	(in millions)	March 31,			December 31,
		2014			2013
	Derivatives designated as hedging instruments
	Assets
	Other current assets	$	1		$	1
	Liabilities
	Other current liabilities	(1		)	—

Accrued_and_Other_Current_Liab

Accrued and Other Current Liabilities	3 Months Ended
	Mar. 31, 2014
Payables and Accruals [Abstract]	'
Accrued and Other Current Liabilities	'
	Accrued and Other Current Liabilities
	(in millions)	March 31,		December 31,
		2014		2013
	Compensation and other employee-benefits	$	197	$	215
	Customer-related liabilities	60		63
	Accrued warranty costs	34		36
	Accrued taxes	70		45
	Other accrued liabilities	127		120
	Total accrued and other current liabilities	$	488	$	479

Credit_Facilities_and_LongTerm

Credit Facilities and Long-Term Debt	3 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Credit Facilities and Long-Term Debt	'
	Credit Facilities and Long-Term Debt
	Total debt outstanding is summarized as follows:
	(in millions)	March 31,			December 31,
		2014			2013
	Short-term borrowings and current maturities of long-term debt	$	44		$	42
	Long-term debt
	3.550% Senior Notes due 2016 (a)	$	600		$	600
	4.875% Senior Notes due 2021 (a)	600			600
	Unamortized discount (b)	(1		)	(1		)
	Long-term debt	$	1,199		$	1,199
	Total debt	$	1,243		$	1,241
	(a)	The fair value of our Senior Notes (as defined below) was determined using quoted prices in active markets for identical securities, which are considered Level 1 inputs. The fair value of our Senior Notes due 2016 (as defined below) was $633 million and $635 million as of March 31, 2014 and December 31, 2013, respectively. The fair value of our Senior Notes due 2021 (as defined below) was $639 million and $629 million as of March 31, 2014 and December 31, 2013, respectively.
	(b)	The unamortized discount is recognized as a reduction in the carrying value of the Senior Notes in the Condensed Consolidated Balance Sheets and is being amortized to interest expense in our Condensed Consolidated Income Statements over the expected remaining terms of the Senior Notes.
	Senior Notes
	On September 20, 2011, we issued 3.550% Senior Notes of $600 million aggregate principal amount due September 2016 (the "Senior Notes due 2016") and 4.875% Senior Notes of $600 million aggregate principal amount due October 2021 (the "Senior Notes due 2021" and together with the Senior Notes due 2016, the "Senior Notes").
	The Senior Notes include covenants which restrict our ability, subject to exceptions, to incur debt secured by liens and engage in sale and lease-back transactions, as well as provide for customary events of default (subject, in certain cases, to receipt of notice of default and/or customary grace and cure periods). We may redeem the Senior Notes, as applicable, in whole or in part, at any time at a redemption price equal to the principal amount of the Senior Notes to be redeemed, plus a make-whole premium. As of March 31, 2014, we were in compliance with all covenants. If a change of control triggering event (as defined in the Senior Notes indenture) occurs, we will be required to make an offer to purchase the Senior Notes at a price equal to 101% of their principal amount plus accrued and unpaid interest to the date of repurchase.
	Interest on the Senior Notes due 2016 is payable on March 20 and September 20 of each year. Interest on the Senior Notes due 2021 is payable on April 1 and October 1 of each year.
	Four Year Competitive Advance and Revolving Credit Facility
	Effective October 31, 2011, Xylem and its subsidiaries entered into a Four Year Competitive Advance and Revolving Credit Facility (the "Credit Facility") with JPMorgan Chase Bank, N.A., as administrative agent, and a syndicate of lenders. The Credit Facility provides for an aggregate principal amount of up to $600 million of (i) a competitive advance borrowing option which will be provided on an uncommitted competitive advance basis through an auction mechanism (the "competitive loans"), (ii) revolving extensions of credit (the "revolving loans") outstanding at any time and (iii) the issuance of letters of credit in a face amount not in excess of $100 million outstanding at any time.
	At our election, the interest rate per annum applicable to the competitive advances will be based on either (i) a Eurodollar rate determined by reference to LIBOR, plus an applicable margin offered by the lender making such loans and accepted by us or (ii) a fixed percentage rate per annum specified by the lender making such loans. At our election, the interest rate per annum applicable to the revolving loans will be based on either (i) a Eurodollar rate determined by reference to LIBOR, adjusted for statutory reserve requirements, plus an applicable margin or (ii) a fluctuating rate of interest determined by reference to the greatest of: (a) the prime rate of JPMorgan Chase Bank, N.A., (b) the U.S. Federal Funds effective rate plus half of 1% or (c) the Eurodollar rate determined by reference to LIBOR, adjusted for statutory reserve requirements, in each case, plus an applicable margin.
	In accordance with the terms, we may not exceed a maximum leverage ratio of 3.50 (based on a ratio of total debt to earnings before interest, taxes, depreciation and amortization) throughout the term. As of March 31, 2014, we were in compliance with all covenants. The Credit Facility also contains limitations on, among other things, incurring debt, granting liens, and entering sale and leaseback transactions. In addition, the Credit Facility contains other terms and conditions such as customary representations and warranties, additional covenants and customary events of default.
	As of March 31, 2014, the Credit Facility remains undrawn.
	Research and Development Facility Agreement
	On December 4, 2013, the Company amended and restated its Risk Sharing Finance Facility Agreement (the "R&D Facility Agreement") with The European Investment Bank (the "EIB") to add an additional borrower under the facility.  The facility provides an aggregate principal amount of up to €120 million (approximately $165 million) to finance research projects and infrastructure development in the European Union. The Company's wholly-owned subsidiaries in Luxembourg, Xylem Holdings S.a.r.l. and Xylem International S.a.r.l., are the borrowers under the R&D Facility Agreement.  The obligations of the borrowers under the R&D Facility Agreement are guaranteed by the Company under an Amended and Restated Deed of Guarantee, dated as of December 4, 2013, in favor of the EIB. The funds are available to finance research and development projects during the period from 2013 through 2016 at the Company's R&D facilities in Sweden, Germany, Italy, the United Kingdom, Austria, Norway and Hungary.
	Under the R&D Facility Agreement, the borrower can draw loans with a maturity of no longer than 12 years. The R&D Facility Agreement provides for Fixed Rate loans and Floating Rate loans. The interest rate per annum applicable to Fixed Rate loans will be at a fixed percentage rate per annum specified by the EIB which includes the applicable margin. The interest rate per annum applicable to Floating Rate loans will be at the rate determined by reference to EURIBOR for loans drawn in Euros and LIBOR for loans drawn in Pounds Sterling or U.S. Dollars, plus an applicable spread specified by the EIB which includes the applicable margin. The applicable margin for both Fixed Rate loans and Floating Rate loans shall be determined by reference to the credit rating of the Company.
	In accordance with the terms of the R&D Facility Agreement, we may not exceed a maximum leverage ratio of 3.50 (based on a ratio of total debt to earnings before interest, taxes, depreciation and amortization) throughout the term. As of March 31, 2014, we were in compliance with all covenants. The R&D Facility Agreement also contains limitations on, among other things, incurring debt, granting liens, and entering sale and leaseback transactions. In addition, the R&D Facility Agreement contains other terms and conditions such as customary representations and warranties, additional covenants and customary events of default.
	As of March 31, 2014, $39 million was outstanding under the R&D Facility Agreement. Although the borrowing term for this arrangement is for five years, we have classified it as short-term debt on our Condensed Consolidated Balance Sheet since we intend to repay this obligation in less than one year.

Postretirement_Benefit_Plans

Postretirement Benefit Plans	3 Months Ended
	Mar. 31, 2014
Compensation and Retirement Disclosure [Abstract]	'
Postretirement Benefit Plans	'
	Postretirement Benefit Plans
	The following table provides the components of net periodic benefit cost for our defined benefit pension plans, disaggregated by domestic and international plans.
		Three Months Ended
		March 31,
	(in millions)	2014			2013
	Domestic defined benefit pension plans:
	Service cost	$	—		$	1
	Interest cost	1			1
	Expected return on plan assets	(1		)	(1		)
	Amortization of net actuarial loss	1			1
	Net periodic benefit cost	$	1		$	2
	International defined benefit pension plans:
	Service cost	$	4		$	3
	Interest cost	7			7
	Expected return on plan assets	(8		)	(8		)
	Amortization of net actuarial loss	2			3
	Net periodic benefit cost	$	5		$	5
	Total net periodic benefit cost	$	6		$	7
	The total net periodic benefit cost for other postretirement employee benefit plans for the three months ended March 31, 2014 and 2013 was $1 million for both periods.
	We contributed $11 million to postretirement benefit plans during both the three months ended March 31, 2014 and 2013. Additional contributions ranging between approximately $30 million and $40 million are expected during the remainder of 2014.

StockBased_Compensation_Plans

Stock-Based Compensation Plans	3 Months Ended
	Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Stock-Based Compensation Plans	'
	Stock-Based Compensation Plans
	Share-based compensation expense was $4 million and $6 million during the three months ended March 31, 2014 and 2013, respectively. The unamortized compensation expense related to our stock options, restricted stock and performance based shares was $8 million, $23 million and $3 million, respectively, at March 31, 2014 and is expected to be recognized over a weighted average period of 2.0, 2.1 and 2.5 years, respectively. The amount of cash received from the exercise of stock options was $11 million and less than $1 million for the three months ended March 31, 2014 and 2013, respectively.
	On March 17, 2014, the Company named Patrick K. Decker as the new President and Chief Executive Officer of Xylem Inc. As part of Mr. Decker's employment agreement, he was awarded 165,584 stock options, 40,342 restricted stock and 40,342 performance-based shares. As the award is subject to shareholder approval of the Xylem Omnibus Incentive Plan at the annual meeting of shareholders in May 2014, all share and associated expense amounts are excluded from the activity in the first quarter of 2014.
	Stock Option Grants
	The following is a summary of the changes in outstanding stock options for the three months ended March 31, 2014:
	(shares in thousands)	Shares		Weighted		Weighted  Average
				Average		Remaining
				Exercise		Contractual
				Price / Share		Term (Years)
	Outstanding at January 1, 2014	3,504		$	26.8	6.4
	Granted	373		$	38.76	10
	Exercised	(386	)	$	27.82	2.8
	Forfeited	(37	)	$	23.4	4
	Outstanding at March 31, 2014	3,454		$	28.01	7
	Options exercisable at March 31, 2014	2,131		$	26.98	6
	Vested and expected to vest as of March 31, 2014	3,339		$	27.81	6.9
	The aggregate intrinsic value of the outstanding, exercisable and vested and expected to vest stock options as of March 31, 2014 was $20 million, $30 million and $29 million, respectively. The total intrinsic value of options exercised (which is the amount by which the stock price exceeded the exercise price of the options on the date of exercise) during the three months ended March 31, 2014 was $4 million.
	Stock Option Fair Value
	The fair value of each option grant was estimated on the date of grant using the binomial lattice pricing model which incorporates multiple and variable assumptions over time, including assumptions such as employee exercise patterns, stock price volatility and changes in dividends. The following are weighted-average assumptions for 2014.
	Dividend yield	1.32		%
	Volatility	28.8		%
	Risk-free interest rate	1.79		%
	Expected term (in years)	5.7
	Weighted-average fair value / share	$	9.99
	Expected volatility is calculated based on a weighted analysis of historic and implied volatility measures for a set of peer companies and Xylem. We use historical data to estimate option exercise and employee termination behavior within the valuation model. Employee groups and option characteristics are considered separately for valuation purposes. The expected term represents an estimate of the period of time options are expected to remain outstanding. The expected term provided above represents the weighted average of expected behavior for certain groups of employees who have historically exhibited different behavior. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of option grant.
	Restricted Stock Grants
	The following is a summary of restricted stock activity for the three months ended March 31, 2014:
	(shares in thousands)	Shares		Weighted
				Average
				Grant Date
				Fair Value /Share
	Outstanding at January 1, 2014	1,275		$	27.67
	Granted	286		$	38.74
	Vested	(182	)	$	32.06
	Forfeited	(24	)	$	27.45
	Outstanding at March 31, 2014	1,355		$	29.45
	Performance-Based Share Grants
	The following is a summary of performance-based share grants for the three months ended March 31, 2014:
	(shares in thousands)	Shares		Weighted
				Average
				Grant Date
				Fair Value /Share
	Outstanding at January 1, 2014	52		$	27.49
	Granted	43		$	38.76
	Vested	—		$	—
	Forfeited	—		$	—
	Outstanding at March 31, 2014	95		$	32.54

Capital_Stock_Capital_Stock

Capital Stock Capital Stock	3 Months Ended
	Mar. 31, 2014
Equity [Abstract]	'
Capital Stock	'
	Capital Stock
	On August 20, 2013, the Board of Directors authorized the repurchase of up to $250 million in shares with no expiration date. The program's objective is to deploy our capital in a manner that benefits our shareholders and maintains our focus on growth. During the three months ended March 31, 2014, we repurchased 1.3 million shares for $50 million under this program. There are up to $150 million in shares that may still be purchased under this plan as of March 31, 2014.
	On August 18, 2012, the Board of Directors authorized the repurchase of up to 2.0 million shares of common stock with no expiration date. The program's objective is to offset dilution associated with various Xylem employee stock plans by acquiring shares in the open market from time to time. There were no shares repurchased under this program during the three months ended March 31, 2014. There were 0.5 million shares repurchased for $14 million under this program during the three months ended March 31, 2013. There are up to 1.0 million shares that may still be purchased under this plan as of March 31, 2014.
	Aside from the aforementioned repurchase programs, we repurchased less than 0.1 million shares for $1 million during both the three months ended March 31, 2014 and 2013, in relation to settlement of employee tax withholding obligations due as a result of the vesting of restricted stock.

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Income (Loss) (Notes)	3 Months Ended
	Mar. 31, 2014
Equity [Abstract]	'
Accumulated Other Comprehensive Income (Loss)	'
	Accumulated Other Comprehensive Income (Loss)
	The following table provides the components of accumulated other comprehensive income (loss) for the three months ended March 31, 2014:
	(in millions)	Foreign Currency Translation			Postretirement Benefit Plans			Derivative Instruments			Total
	Balance at January 1, 2014	$	351		$	(186	)	$	2		$	167
	Foreign currency translation adjustment	(2		)	—			—			(2		)
	Amortization of net actuarial loss on postretirement benefit plans into:
	Cost of revenue	—			1			—			1
	Selling, general and administrative expenses	—			2			—			2
	Income tax expense on amortization of postretirement benefit plan items	—			(1		)	—			(1		)
	Loss on foreign exchange agreements	—			—			(1		)	(1		)
	Reclassification of gain on foreign exchange agreements into revenue	—			—			(1		)	(1		)
	Reclassification of loss on foreign exchange agreements into cost of revenue	—			—			1			1
	Balance at March 31, 2014	$	349		$	(184	)	$	1		$	166

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	Commitments and Contingencies
	General
	From time to time, we are involved in legal proceedings that are incidental to the operation of our businesses, including acquisitions and divestitures, intellectual property matters, product liability and personal injury claims, employment and pension matters, government and commercial contract disputes.
	We are currently involved in litigation relation to a purchase price dispute with the minority shareholders arising from one of our historical acquisitions. The court recently announced its decision to increase the purchase price to be paid to such minority shareholders, and both sides are appealing that decision.
	From time to time claims may be asserted against Xylem alleging injury caused by any of our products resulting from asbestos exposure. We believe there are numerous legal defenses available for such claims and would defend ourselves vigorously. Pursuant to the Distribution Agreement ("Distribution Agreement") dated October 25, 2011 among ITT Corporation ("ITT" or "former parent"), Exelis Inc. and Xylem, the former parent has an obligation to indemnify, defend and hold Xylem harmless for asbestos product liability matters, including settlements, judgments, and legal defense costs associated with all pending and future claims that may arise from past sales of the former parent’s legacy products. We believe the former parent remains a substantial entity with sufficient financial resources to honor its obligations to us.
	Although the ultimate outcome of any legal matter cannot be predicted with certainty, based on present information, including our assessment of the merits of the particular claims, we do not expect that any asserted or unasserted legal claims or proceedings, individually or in aggregate, will have a material adverse effect on our results of operations or financial condition. We have estimated and accrued $17 million as of both March 31, 2014 and December 31, 2013 for these general legal matters.
	Indemnifications
	As part of our 2011 Spin-off from our former parent, Exelis Inc., ITT and Xylem will indemnify, defend and hold harmless each of the other parties with respect to such parties’ assumed or retained liabilities under the Distribution Agreement and breaches of the Distribution Agreement or related spin agreements. The former parent’s indemnification obligations include asserted and unasserted asbestos and silica liability claims that relate to the presence or alleged presence of asbestos or silica in products manufactured, repaired or sold prior to October 31, 2011, the Distribution Date, subject to limited exceptions with respect to certain employee claims, or in the structure or material of any building or facility, subject to exceptions with respect to employee claims relating to Xylem buildings or facilities. The indemnification associated with pending and future asbestos claims does not expire. Xylem has not recorded a liability for material matters for which we expect to be indemnified by the former parent or Exelis Inc. through the Distribution Agreement and we are not aware of any claims or other circumstances that would give rise to material payments from us under such indemnifications.
	Environmental
	In the ordinary course of business, we are subject to federal, state, local, and foreign environmental laws and regulations. We are responsible, or are alleged to be responsible, for ongoing environmental investigation and remediation of sites in various countries. These sites are in various stages of investigation and/or remediation and in many of these proceedings our liability is considered de minimis. We have received notification from the U.S. Environmental Protection Agency, and from similar state and foreign environmental agencies, that a number of sites formerly or currently owned and/or operated by Xylem or for which we are responsible under the Distribution Agreement, and other properties or water supplies that may be or have been impacted from those operations, contain disposed or recycled materials or wastes and require environmental investigation and/or remediation. These sites include instances where we have been identified as a potentially responsible party under federal and state environmental laws and regulations.
	Accruals for environmental matters are recorded on a site-by-site basis when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. Our accrued liabilities for these environmental matters represent the best estimates related to the investigation and remediation of environmental media such as water, soil, soil vapor, air and structures, as well as related legal fees. These estimates, and related accruals, are reviewed quarterly and updated for progress of investigation and remediation efforts and changes in facts and legal circumstances. Liabilities for these environmental expenditures are recorded on an undiscounted basis. We have estimated and accrued $7 million and $8 million as of March 31, 2014 and December 31, 2013 for environmental matters, respectively.
	It is difficult to estimate the final costs of investigation and remediation due to various factors, including incomplete information regarding particular sites and other potentially responsible parties, uncertainty regarding the extent of investigation or remediation and our share, if any, of liability for such conditions, the selection of alternative remedial approaches, and changes in environmental standards and regulatory requirements. We believe the total amount accrued is reasonable based on existing facts and circumstances.
	Our estimate of reasonably possible losses in excess of amounts accrued for environmental and legal matters was approximately $29 million and $26 million as of March 31, 2014 and December 31, 2013, respectively.
	Warranties
	We warrant numerous products, the terms of which vary widely. In general, we warrant products against defect and specific non-performance. The table below provides the changes in our product warranty accrual.
	(in millions)	2014			2013
	Warranty accrual – January 1	$	37		$	40
	Net changes for product warranties in the period	5			8
	Settlement of warranty claims	(8		)	(8		)
	Warranty accrual – March 31	$	34		$	40

Segment_Information

Segment Information	3 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
Segment Information	'
	Segment Information
	Our business is organized into two segments: Water Infrastructure and Applied Water. The Water Infrastructure segment, comprising our Water Solutions and Analytics operating units, focuses on the transportation, treatment and testing of water, offering a range of products including water and wastewater pumps, treatment and testing equipment, and controls and systems. The Applied Water segment, comprising our Residential & Commercial Water and Flow Control operating units, encompasses the uses of water and focuses on the residential, commercial, industrial and agricultural markets offering a wide range of products, including pumps, valves and heat exchangers. Corporate and other consists of corporate office expenses including compensation, benefits, occupancy, depreciation, and other administrative costs, as well as charges related to certain matters, such as environmental matters that are managed at a corporate level and are not included in the business segments in evaluating performance or allocating resources.
	The accounting policies of each segment are the same as those described in the summary of significant accounting policies (see Note 1 in the 2013 Annual Report). The following tables contain financial information for each reportable segment.
		Three Months Ended
		March 31,
	(in millions)	2014			2013
	Revenue:
	Water Infrastructure	$	568		$	551
	Applied Water	355			345
	Eliminations	(17		)	(17		)
	Total	$	906		$	879
	Operating Income:
	Water Infrastructure	$	46		$	42
	Applied Water	41			40
	Corporate and other	(11		)	(16		)
	Total	$	76		$	66
	Depreciation and Amortization:
	Water Infrastructure	$	27		$	28
	Applied Water	7			8
	Corporate and other	2			1
	Total	$	36		$	37
	Capital Expenditures:
	Water Infrastructure	$	14		$	18
	Applied Water	8			11
	Corporate and other	3			1
	Total	$	25		$	30
	The following table contains the total assets for each reportable segment.
		Total Assets
	(in millions)	March 31,			December 31,
		2014			2013
	Water Infrastructure	$	2,986		$	2,989
	Applied Water	1,379			1,340
	Corporate and other (a)	522			567
	Total	$	4,887		$	4,896
	(a)	Corporate and other consists of items pertaining to our corporate headquarters function, which principally consist of cash, deferred tax assets, pension assets and certain property, plant and equipment.

Background_and_Basis_of_Presen1

Background and Basis of Presentation (Policies)	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Basis of Presentation	'
	Basis of Presentation
	The interim condensed consolidated financial statements reflect our financial position and results of operations in conformity with accounting principles generally accepted in the United States of America ("GAAP"). All transactions between our businesses have been eliminated.
	The unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and, in the opinion of management, reflect all adjustments (which include normal recurring adjustments) considered necessary for a fair presentation of the financial position and results of operations for the periods presented. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such SEC rules. We believe that the disclosures made are adequate to make the information presented not misleading. We consistently applied the accounting policies described in our Annual Report on Form 10-K for the year ended December 31, 2013 ("2013 Annual Report") in preparing these unaudited condensed consolidated financial statements, with the exception of accounting standard updates described in Note 2. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in our 2013 Annual Report. Certain prior year amounts have been reclassified to conform to the current year presentation.
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Estimates are revised as additional information becomes available. Estimates and assumptions are used for, but not limited to, postretirement obligations and assets, revenue recognition, income tax contingency accruals and valuation allowances, goodwill impairment testing and contingent liabilities. Actual results could differ from these estimates. Additionally, our interim condensed consolidated financial statements may not be indicative of our future performance.
	Our quarterly financial periods end on the Saturday closest to the last day of the calendar quarter, except for the fourth quarter which ends on December 31. For ease of presentation, the condensed consolidated financial statements included herein are described as ending on the last day of the calendar quarter.

Restructuring_Charges_Tables

Restructuring Charges (Tables)	3 Months Ended
	Mar. 31, 2014
Restructuring and Related Activities [Abstract]	'
Components of restructuring and asset imparment charges	'
	During the three months ended March 31, 2014, we recognized restructuring charges of $15 million. We incurred these charges primarily in an effort to reposition our European and North American business to optimize our cost structure and improve our operational efficiency and effectiveness. The charges relate to the reduction in structural costs, including the elimination of headcount and consolidation of facilities within both our Water Infrastructure and Applied Water segments. During the three months ended March 31, 2013 we recognized restructuring charges of $5 million. These charges related to the reduction in structural costs, including the consolidation of facilities, within our Water Infrastructure segment.
	The following table presents the components of restructuring expense for the three months ended March 31, 2014 and 2013.
		Three Months Ended
		March 31,
	(in millions)	2014				2013
	By component:
	Severance and other charges	$	15			$	5
	Reversal of restructuring accruals	—				—
	Total restructuring charges	$	15			$	5
	By segment:
	Water Infrastructure	$	10			$	5
	Applied Water	5				—
	Corporate and other	—				—
Restructuring Accruals	'
	The following table displays a rollforward of the restructuring accruals, presented on our Condensed Consolidated Balance Sheets within accrued and other current liabilities, for the three months ended March 31, 2014 and 2013.
	(in millions)		2014				2013
	Restructuring accruals - January 1		$	13			$	9
	Restructuring charges		15				5
	Cash payments		(9		)		(4		)
	Restructuring accruals - March 31		$	19			$	10
	By segment:
	Water Infrastructure		$	14			$	7
	Applied Water		5				3
	Corporate and other		—				—
Planned Employee Reductions Associatied with Restructuring	'
	The following is a rollforward of employee position eliminations associated with restructuring activities for the three months ended March 31, 2014 and 2013.
			2014			2013
	Planned reductions - January 1		51			54
	Additional planned reductions		170			99
	Actual reductions		(109	)		(52	)
	Planned reductions - March 31		112			101

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Basic and diluted net earnings per share	'
		Three Months Ended
		March 31,
		2014			2013
	Net income (in millions)	$	49		$	41
	Shares (in thousands):
	Weighted average common shares outstanding	184,505			185,573
	Add: Participating securities (a)	42			234
	Weighted average common shares outstanding — Basic	184,547			185,807
	Plus incremental shares from assumed conversions: (b)
	Dilutive effect of stock options	659			178
	Dilutive effect of restricted stock	563			450
	Weighted average common shares outstanding — Diluted	185,769			186,435
	Basic earnings per share	$	0.27		$	0.22
	Diluted earnings per share	$	0.27		$	0.22
	(a)	Restricted stock awards containing rights to non-forfeitable dividends that participate in undistributed earnings with common shareholders are considered participating securities for purposes of computing earnings per share.
	(b)	Incremental shares from stock options, restricted stock and performance share units are computed by the treasury stock method. The weighted average shares listed below were not included in the computation of diluted earnings per share because to do so would have been anti-dilutive for the periods presented or were otherwise excluded under the treasury stock method. The treasury stock method calculates dilution assuming the exercise of all in-the-money options and vesting of restricted stock and performance share awards, reduced by the repurchase of shares with the proceeds from the assumed exercises, unrecognized compensation expense for outstanding awards and the estimated tax benefit of the assumed exercises. Performance share units will be included in the treasury stock calculation of diluted earnings per share upon achievement of underlying performance conditions. See Note 14, "Stock-Based Compensation Plans" for further detail on the performance share units.
		Three Months Ended
		March 31,
	(in thousands)	2014		2013
	Stock options	2,746		4,130
	Restricted stock	449		757
	Performance shares	69		40

Inventories_Tables

Inventories (Tables)	3 Months Ended
	Mar. 31, 2014
Inventory Disclosure [Abstract]	'
Inventories	'
	(in millions)	March 31,		December 31,
		2014		2013
	Finished goods	$	212	$	189
	Work in process	35		31
	Raw materials	269		255
	Total inventories, net	$	516	$	475

Property_Plant_and_Equipment_T

Property, Plant and Equipment (Tables)	3 Months Ended
	Mar. 31, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment	'
	(in millions)	March 31,		December 31,
		2014		2013
	Land, buildings and improvements	$	256	$	263
	Machinery and equipment	686		685
	Equipment held for lease or rental	197		192
	Furniture and fixtures	94		93
	Construction work in progress	50		49
	Other	22		22
	Total property, plant and equipment, gross	1,305		1,304
	Less accumulated depreciation	829		816
	Total property, plant and equipment, net	$	476	$	488

Goodwill_and_Other_Intangible_1

Goodwill and Other Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Changes in the carrying value of goodwill by operating segment	'
	Changes in the carrying value of goodwill by reportable segment for the three months ended March 31, 2014 are as follows:
	(in millions)	Water		Applied Water			Total
		Infrastructure
	Balance as of January 1, 2014	$	1,149	$	569		$	1,718
	Activity in 2014
	Foreign currency and other	2		(1		)	1
	Balance as of March 31, 2014	$	1,151	$	568		$	1,719
Other Intangible Assets	'
	Information regarding our other intangible assets is as follows:
		31-Mar-14							December 31, 2013
	(in millions)	Carrying		Accumulated			Net		Carrying		Accumulated			Net
		Amount		Amortization			Intangibles		Amount		Amortization			Intangibles
	Customer and distributor relationships	$	350	$	(109	)	$	241	$	352	$	(104	)	$	248
	Proprietary technology	109		(38		)	71		109		(36		)	73
	Trademarks	35		(16		)	19		35		(16		)	19
	Patents and other	23		(19		)	4		20		(17		)	3
	Indefinite-lived intangibles	145		—			145		145		—			145
		$	662	$	(182	)	$	480	$	661	$	(173	)	$	488

Derivative_Financial_Instrumen1

Derivative Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Outstanding foreign currency derivatives used to hedge foreign exchange risks	'
	Listed in the table below are the outstanding foreign currency derivatives that were used to hedge foreign exchange risks as of March 31, 2014.
	(in millions; except number of instruments)
	Foreign Currency Derivative		Number of		Total Notional			Sell Notional Currency	Total Notional	Buy Notional
			Instruments		Sold				Purchased	Currency
	Buy HUF/Sell EUR forward		8		8			Euro (EUR)	2,410	Hungarian Forint (HUF)
	Buy PLN/ Sell EUR forward		16		19			Euro (EUR)	78	Polish Zloty (PLN)
	Buy SEK/Sell EUR forward		8		100			Euro (EUR)	903	Swedish Krona (SEK)
	Sell AUD/Buy EUR Forward		16		20			Australian Dollar (AUD)	13	Euro (EUR)
	Sell AUD/Buy USD Forward		7		6			Australian Dollar (AUD)	6	United States Dollar (USD)
	Sell GBP/Buy EUR forward		21		33			British Pound Sterling (GBP)	40	Euro (EUR)
	Sell USD/Buy EUR Forward		36		105			United States Dollar (USD)	76	Euro (EUR)
Effect of derivative financial instruments	'
	The table below presents the effect of our derivative financial instruments on the Condensed Consolidated Income Statements and Statements of Comprehensive Income.
		Three Months Ended
		March 31,
	(in millions)	2014			2013
	Derivatives in Cash Flow Hedges
	Foreign Exchange Contracts
	Amount of gain (loss) recognized in Other Comprehensive Income (a)	$	(1	)	$	(2	)
	Amount of (gain) loss reclassified from Other Comprehensive Income into revenue (a)	(1		)	(1		)
	Amount of (gain) loss reclassified from Other Comprehensive Income into cost of revenue (a)	1			—
	(a)	Effective portion
Fair values of foreign exchange contracts	'
	The fair values of our foreign exchange contracts currently included in our hedging program were as follows:
	(in millions)	March 31,			December 31,
		2014			2013
	Derivatives designated as hedging instruments
	Assets
	Other current assets	$	1		$	1
	Liabilities
	Other current liabilities	(1		)	—

Accrued_and_Other_Current_Liab1

Accrued and Other Current Liabilities (Tables)	3 Months Ended
	Mar. 31, 2014
Payables and Accruals [Abstract]	'
Accrued and Other Current Liabilities	'
	(in millions)	March 31,		December 31,
		2014		2013
	Compensation and other employee-benefits	$	197	$	215
	Customer-related liabilities	60		63
	Accrued warranty costs	34		36
	Accrued taxes	70		45
	Other accrued liabilities	127		120
	Total accrued and other current liabilities	$	488	$	479

Credit_Facilities_and_LongTerm1

Credit Facilities and Long-Term Debt (Tables)	3 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Schedule of Credit Facilities and Long-Term Debt	'
	(in millions)	March 31,			December 31,
		2014			2013
	Short-term borrowings and current maturities of long-term debt	$	44		$	42
	Long-term debt
	3.550% Senior Notes due 2016 (a)	$	600		$	600
	4.875% Senior Notes due 2021 (a)	600			600
	Unamortized discount (b)	(1		)	(1		)
	Long-term debt	$	1,199		$	1,199
	Total debt	$	1,243		$	1,241
	(a)	The fair value of our Senior Notes (as defined below) was determined using quoted prices in active markets for identical securities, which are considered Level 1 inputs. The fair value of our Senior Notes due 2016 (as defined below) was $633 million and $635 million as of March 31, 2014 and December 31, 2013, respectively. The fair value of our Senior Notes due 2021 (as defined below) was $639 million and $629 million as of March 31, 2014 and December 31, 2013, respectively.
	(b)	The unamortized discount is recognized as a reduction in the carrying value of the Senior Notes in the Condensed Consolidated Balance Sheets and is being amortized to interest expense in our Condensed Consolidated Income Statements over the expected remaining terms of the Senior Notes.

Postretirement_Benefit_Plans_T

Postretirement Benefit Plans (Tables)	3 Months Ended
	Mar. 31, 2014
Compensation and Retirement Disclosure [Abstract]	'
Components of net periodic benefit cost and other amounts recognized in other comprehensive income	'
	he following table provides the components of net periodic benefit cost for our defined benefit pension plans, disaggregated by domestic and international plans.
		Three Months Ended
		March 31,
	(in millions)	2014			2013
	Domestic defined benefit pension plans:
	Service cost	$	—		$	1
	Interest cost	1			1
	Expected return on plan assets	(1		)	(1		)
	Amortization of net actuarial loss	1			1
	Net periodic benefit cost	$	1		$	2
	International defined benefit pension plans:
	Service cost	$	4		$	3
	Interest cost	7			7
	Expected return on plan assets	(8		)	(8		)
	Amortization of net actuarial loss	2			3
	Net periodic benefit cost	$	5		$	5
	Total net periodic benefit cost	$	6		$	7

StockBased_Compensation_Plans_

Stock-Based Compensation Plans (Tables)	3 Months Ended
	Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Summary of restricted stock activity	'
	The following is a summary of restricted stock activity for the three months ended March 31, 2014:
	(shares in thousands)	Shares		Weighted
				Average
				Grant Date
				Fair Value /Share
	Outstanding at January 1, 2014	1,275		$	27.67
	Granted	286		$	38.74
	Vested	(182	)	$	32.06
	Forfeited	(24	)	$	27.45
	Outstanding at March 31, 2014	1,355		$	29.45
Summary of performance based share grants	'
	The following is a summary of performance-based share grants for the three months ended March 31, 2014:
	(shares in thousands)	Shares		Weighted
				Average
				Grant Date
				Fair Value /Share
	Outstanding at January 1, 2014	52		$	27.49
	Granted	43		$	38.76
	Vested	—		$	—
	Forfeited	—		$	—
	Outstanding at March 31, 2014	95		$	32.54
Summary of the changes in outstanding stock options	'
	The following is a summary of the changes in outstanding stock options for the three months ended March 31, 2014:
	(shares in thousands)	Shares		Weighted		Weighted  Average
				Average		Remaining
				Exercise		Contractual
				Price / Share		Term (Years)
	Outstanding at January 1, 2014	3,504		$	26.8	6.4
	Granted	373		$	38.76	10
	Exercised	(386	)	$	27.82	2.8
	Forfeited	(37	)	$	23.4	4
	Outstanding at March 31, 2014	3,454		$	28.01	7
	Options exercisable at March 31, 2014	2,131		$	26.98	6
	Vested and expected to vest as of March 31, 2014	3,339		$	27.81	6.9
Weighted-average assumptions for annual March 2014 grants	'
	The following are weighted-average assumptions for 2014.
	Dividend yield	1.32		%
	Volatility	28.8		%
	Risk-free interest rate	1.79		%
	Expected term (in years)	5.7
	Weighted-average fair value / share	$	9.99

Accumulated_Other_Comprehensiv1

Accumulated Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Mar. 31, 2014
Equity [Abstract]	'
Schedule of Accumulated Other Comprehensive Income (Loss)	'
	The following table provides the components of accumulated other comprehensive income (loss) for the three months ended March 31, 2014:
	(in millions)	Foreign Currency Translation			Postretirement Benefit Plans			Derivative Instruments			Total
	Balance at January 1, 2014	$	351		$	(186	)	$	2		$	167
	Foreign currency translation adjustment	(2		)	—			—			(2		)
	Amortization of net actuarial loss on postretirement benefit plans into:
	Cost of revenue	—			1			—			1
	Selling, general and administrative expenses	—			2			—			2
	Income tax expense on amortization of postretirement benefit plan items	—			(1		)	—			(1		)
	Loss on foreign exchange agreements	—			—			(1		)	(1		)
	Reclassification of gain on foreign exchange agreements into revenue	—			—			(1		)	(1		)
	Reclassification of loss on foreign exchange agreements into cost of revenue	—			—			1			1
	Balance at March 31, 2014	$	349		$	(184	)	$	1		$	166

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Changes in product warranty accrual	'
	We warrant numerous products, the terms of which vary widely. In general, we warrant products against defect and specific non-performance. The table below provides the changes in our product warranty accrual.
	(in millions)	2014			2013
	Warranty accrual – January 1	$	37		$	40
	Net changes for product warranties in the period	5			8
	Settlement of warranty claims	(8		)	(8		)
	Warranty accrual – March 31	$	34		$	40

Segment_Information_Tables

Segment Information (Tables)	3 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
Financial information for each reportable segment	'
	The accounting policies of each segment are the same as those described in the summary of significant accounting policies (see Note 1 in the 2013 Annual Report). The following tables contain financial information for each reportable segment.
		Three Months Ended
		March 31,
	(in millions)	2014			2013
	Revenue:
	Water Infrastructure	$	568		$	551
	Applied Water	355			345
	Eliminations	(17		)	(17		)
	Total	$	906		$	879
	Operating Income:
	Water Infrastructure	$	46		$	42
	Applied Water	41			40
	Corporate and other	(11		)	(16		)
	Total	$	76		$	66
	Depreciation and Amortization:
	Water Infrastructure	$	27		$	28
	Applied Water	7			8
	Corporate and other	2			1
	Total	$	36		$	37
	Capital Expenditures:
	Water Infrastructure	$	14		$	18
	Applied Water	8			11
	Corporate and other	3			1
	Total	$	25		$	30
Total assets for each reportable segment	'
	The following table contains the total assets for each reportable segment.
		Total Assets
	(in millions)	March 31,			December 31,
		2014			2013
	Water Infrastructure	$	2,986		$	2,989
	Applied Water	1,379			1,340
	Corporate and other (a)	522			567
	Total	$	4,887		$	4,896

Background_and_Basis_of_Presen2

Background and Basis of Presentation (Details)	3 Months Ended
	Mar. 31, 2014
	Segment
Background and Basis of Presentation (Textual) [Abstract]	'
Number of operating segment	2

Acquisitions_Details

Acquisitions (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
		company
Business Combinations [Abstract]	'	'
Cash payment to acquire business	'	$81
Total spent on business acquisitions	$0	$78
Number of Businesses Acquired	'	2

Restructuring_Charges_Restruct

Restructuring Charges (Restructuring and Asset Impaiment Charges) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Restructuring Cost and Impairment Charge	'	'
Severance and other charges	$15	$5
Reversal of restructuring accruals	0	0
Restructuring charges	15	5
Water Infrastructure	'	'
Restructuring Cost and Impairment Charge	'	'
Restructuring charges	10	5
Applied Water	'	'
Restructuring Cost and Impairment Charge	'	'
Restructuring charges	5	0
Corporate and other	'	'
Restructuring Cost and Impairment Charge	'	'
Restructuring charges	$0	$0

Restructuring_Charges_Accrual_

Restructuring Charges (Accrual Rollfoward) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Restructuring Reserve [Roll Forward]	'	'
Restructuring accruals	$13	$9
Restructuring charges	15	5
Cash payments	-9	-4
Restructuring accruals	19	10
Water Infrastructure	'	'
Restructuring Reserve [Roll Forward]	'	'
Restructuring charges	10	5
Restructuring accruals	14	7
Applied Water	'	'
Restructuring Reserve [Roll Forward]	'	'
Restructuring charges	5	0
Restructuring accruals	5	3
Corporate and other	'	'
Restructuring Reserve [Roll Forward]	'	'
Restructuring charges	0	0
Restructuring accruals	$0	$0

Restructuring_Charges_Number_o

Restructuring Charges (Number of Positions Eliminated Rollfoward) (Details)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
	Employees	Employees
Restructuring and Related Cost, Number of Positions Eliminated [Roll Forward]	'	'
Planned reductions - January 1	51	54
Additional planned reductions	170	99
Actual reductions	-109	-52
Planned reductions - March 31	112	101

Restructuring_Charges_Textuals

Restructuring Charges (Textuals) (Details) (USD $)

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Water Infrastructure

Water Infrastructure

Applied Water

Applied Water

2014 Restructuring Plan

2014 Restructuring Plan

2013 Restructuring Plan

2013 Restructuring Plan

2013 Restructuring Plan

2013 Restructuring Plan

Water Infrastructure

Applied Water

Water Infrastructure

Water Infrastructure

Applied Water

Applied Water

Restructuring Cost and Reserve [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Restructuring charges

$15

$5

$10

$5

$5

$0

'

'

'

'

'

'

Restructuring and related cost, expected cost

'

'

'

'

'

'

10

7

'

33

'

10

Restructuring and Related Cost, Incurred Cost

'

'

'

'

'

'

9

5

1

31

'

8

Restructuring and Related Cost, Expected Cost Remaining

'

'

'

'

'

'

'

'

$1

'

$2

'

Income_Taxes_Details

Income Taxes (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Income Taxes (Textual) [Abstract]	'	'
Income tax provision	$12	$10
Effective tax rate	19.10%	19.10%
Likelihood of uncertain tax positions	'greater than 50%	'
Tax benefit	50.00%	'
Unrecognized tax benefits	30	'
Interest accrued for unrecognized tax benefits	$1	'

Earnings_Per_Share_Details

Earnings Per Share (Details) (USD $)	3 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Mar. 31, 2014		Mar. 31, 2013
Basic and diluted net earnings per share:	'		'
Net income	$49		$41
Shares	'		'
Weighted average common shares outstanding	184,505		185,573
Add: Participating securities	42	[1]	234	[1]
Weighted average common shares outstanding - Basic (in shares)	184,547		185,807
Plus incremental shares from assumed conversions:	'		'
Weighted average common shares outstanding - Diluted (in shares)	185,769		186,435
Basic earnings per share (usd per share)	$0.27		$0.22
Diluted earnings per share (usd per share)	$0.27		$0.22
Stock Options	'		'
Plus incremental shares from assumed conversions:	'		'
Dilutive effect of common shares	659	[2]	178	[2]
Restricted Stock	'		'
Plus incremental shares from assumed conversions:	'		'
Dilutive effect of common shares	563	[2]	450	[2]
[1]	Restricted stock awards containing rights to non-forfeitable dividends that participate in undistributed earnings with common shareholders are considered participating securities for purposes of computing earnings per share.
[2]	Incremental shares from stock options, restricted stock and performance share units are computed by the treasury stock method. The weighted average shares listed below were not included in the computation of diluted earnings per share because to do so would have been anti-dilutive for the periods presented or were otherwise excluded under the treasury stock method. The treasury stock method calculates dilution assuming the exercise of all in-the-money options and vesting of restricted stock and performance share awards, reduced by the repurchase of shares with the proceeds from the assumed exercises, unrecognized compensation expense for outstanding awards and the estimated tax benefit of the assumed exercises. Performance share units will be included in the treasury stock calculation of diluted earnings per share upon achievement of underlying performance conditions. See Note 14, "Stock-Based Compensation Plans" for further detail on the performance share units.

Earnings_Per_Share_Details_1

Earnings Per Share (Details 1)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Stock Options	'	'
Incremental shares from stock options and restricted stock:	'	'
Stock Options/ Restricted Shares	2,746	4,130
Restricted Stock	'	'
Incremental shares from stock options and restricted stock:	'	'
Stock Options/ Restricted Shares	449	757
Performance Based Shares	'	'
Incremental shares from stock options and restricted stock:	'	'
Stock Options/ Restricted Shares	69	40

Inventories_Details

Inventories (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Inventories	'	'
Finished goods	$212	$189
Work in process	35	31
Raw materials	269	255
Total inventories, net	$516	$475

Property_Plant_and_Equipment_D

Property, Plant and Equipment (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Property, Plant and Equipment	'	'
Property, plant and equipment, gross	$1,305	$1,304
Less accumulated depreciation	829	816
Total property, plant and equipment, net	476	488
Land, buildings and improvements	'	'
Property, Plant and Equipment	'	'
Property, plant and equipment, gross	256	263
Machinery and equipment	'	'
Property, Plant and Equipment	'	'
Property, plant and equipment, gross	686	685
Equipment held for lease or rental	'	'
Property, Plant and Equipment	'	'
Property, plant and equipment, gross	197	192
Furniture and fixtures	'	'
Property, Plant and Equipment	'	'
Property, plant and equipment, gross	94	93
Construction work in progress	'	'
Property, Plant and Equipment	'	'
Property, plant and equipment, gross	50	49
Other	'	'
Property, Plant and Equipment	'	'
Property, plant and equipment, gross	$22	$22

Property_Plant_and_Equipment_D1

Property, Plant and Equipment (Details Textual) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Property Plant And Equipment (Textual) [Abstract]	'	'
Depreciation expense	$23	$25

Goodwill_and_Other_Intangible_2

Goodwill and Other Intangible Assets (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014
Changes in the carrying value of goodwill by operating segment	'
Balance as of December 31, 2012	$1,718
Foreign currency and other	1
Balance as of March 31, 2013	1,719
Water Infrastructure	'
Changes in the carrying value of goodwill by operating segment	'
Balance as of December 31, 2012	1,149
Foreign currency and other	2
Balance as of March 31, 2013	1,151
Applied Water	'
Changes in the carrying value of goodwill by operating segment	'
Balance as of December 31, 2012	569
Foreign currency and other	-1
Balance as of March 31, 2013	$568

Goodwill_and_Other_Intangible_3

Goodwill and Other Intangible Assets (Details 1) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
Finite-Lived Intangible Assets	'	'	'
Amortization	$9	$9	'
Goodwill and Other Intangible Assets	'	'	'
Accumulated Amortization	-182	'	-173
Intangible Assets Gross, Carrying Amount	662	'	661
Intangible Assets, Net Intangibles	480	'	488
Customer and distributor relationships	'	'	'
Goodwill and Other Intangible Assets	'	'	'
Carrying Amount	350	'	352
Accumulated Amortization	-109	'	-104
Net Intangibles	241	'	248
Proprietary technology	'	'	'
Goodwill and Other Intangible Assets	'	'	'
Carrying Amount	109	'	109
Accumulated Amortization	-38	'	-36
Net Intangibles	71	'	73
Trademarks	'	'	'
Goodwill and Other Intangible Assets	'	'	'
Carrying Amount	35	'	35
Accumulated Amortization	-16	'	-16
Net Intangibles	19	'	19
Patents and other	'	'	'
Goodwill and Other Intangible Assets	'	'	'
Carrying Amount	23	'	20
Accumulated Amortization	-19	'	-17
Net Intangibles	4	'	3
Indefinite-lived intangibles	'	'	'
Goodwill and Other Intangible Assets	'	'	'
Accumulated Amortization	0	'	0
Indefinite-lived intangibles	$145	'	$145

Goodwill_and_Other_Intangible_4

Goodwill and Other Intangible Assets (Details Textual) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Goodwill and Other Intangible Assets (Textual) [Abstract]	'	'
Impairment of goodwill	$0	'
Impairment of the indefinite-lived intangibles	0	'
Amortization expense related to finite-lived intangible assets	$9	$9

Derivative_Financial_Instrumen2

Derivative Financial Instruments (Details)

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

In Millions, unless otherwise specified

Sell EUR Buy HUF forward

Sell EUR Buy HUF forward

Sell EUR Buy PLN forward

Sell EUR Buy PLN forward

Buy SEK Sell EUR forward

Buy SEK Sell EUR forward

Sell AUD Buy EUR forward

Sell AUD Buy EUR forward

Sell AUD Buy USD forward

Sell AUD Buy USD forward

Sell GBP Buy EUR forward

Sell GBP Buy EUR forward

Sell USD Buy EUR forward

Sell USD Buy EUR forward

EUR (€)

PLN

EUR (€)

HUF

CAD

EUR (€)

EUR (€)

SEK

USD ($)

EUR (€)

AUD

EUR (€)

EUR (€)

GBP (£)

Instruments

Instruments

Instruments

Instruments

Instruments

Instruments

Instruments

Derivative Financial Instruments

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of Instruments

8

8

16

16

8

8

16

16

7

7

21

21

36

36

Total Notional Sold

€ 8

'

€ 19

'

100

'

€ 20

'

$6

'

33

'

'

£ 105

Total Notional Purchased

'

2,410

'

78

'

€ 903

'

13

'

€ 6

'

€ 40

€ 76

'

Derivative_Financial_Instrumen3

Derivative Financial Instruments (Details 1) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014		Mar. 31, 2013
Derivative Financial Instruments	'		'
Amount of gain (loss) recognized in OCI on derivative	($1)		($2)
Foreign Exchange Contract	'		'
Derivative Financial Instruments	'		'
Amount of gain (loss) recognized in OCI on derivative	-1	[1]	-2	[1]
Amount of (gain) loss reclassified from OCI into revenue	-1	[1]	-1	[1]
Amount of gain (loss) reclassified from OCI into cost of revenue	$1	[1]	$0	[1]
[1]	Effective portion

Derivative_Financial_Instrumen4

Derivative Financial Instruments (Details 2) (Derivatives designated as hedging instruments, USD $)	Mar. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Other Current Assets [Member]	'	'
Derivatives, Fair Value	'	'
Foreign Currency Contract, Asset, Fair Value Disclosure	$1	$1
Other current liabilities	'	'
Liabilities	'	'
Fair value	($1)	$0

Derivative_Financial_Instrumen5

Derivative Financial Instruments (Details Textual) (USD $)	Mar. 31, 2014
In Millions, unless otherwise specified
Derivative Financial Instruments (Textual) [Abstract]	'
Net unrealized losses on cash flow hedges	$1

Accrued_and_Other_Current_Liab2

Accrued and Other Current Liabilities (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Accrued and Other Current Liabilities	'	'	'	'
Compensation and other employee-benefits	$197	$215	'	'
Customer-related liabilities	60	63	'	'
Accrued warranty costs	34	37	40	40
Product Warranty Accrual, Current	'	36	'	'
Accrued income taxes	70	45	'	'
Other accrued liabilities	127	120	'	'
Total accrued and other current liabilities	$488	$479	'	'

Credit_Facilities_and_LongTerm2

Credit Facilities and Long-Term Debt (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Sep. 20, 2011
In Millions, unless otherwise specified
Debt Instrument	'	'	'
Short-term borrowings and current maturities of long-term debt	$44	$42	'
Credit Facilities and Long-Term Debt :	'	'	'
Unamortized discount	-1	-1	'
Long-term debt	1,199	1,199	'
Total debt	1,243	1,241	'
Senior Notes Due 2016, 3.550%	'	'	'
Credit Facilities and Long-Term Debt :	'	'	'
Senior Notes Due	600	600	600
Senior Notes Due 2021, 4.875%	'	'	'
Credit Facilities and Long-Term Debt :	'	'	'
Senior Notes Due	$600	$600	$600

Credit_Facilities_and_LongTerm3

Credit Facilities and Long-Term Debt (Details Textual)

Oct. 31, 2011

Mar. 31, 2014

Oct. 31, 2011

Mar. 31, 2014

Dec. 14, 2012

Sep. 20, 2011

Mar. 31, 2014

Dec. 31, 2013

Sep. 20, 2011

Mar. 31, 2014

Dec. 31, 2013

Sep. 20, 2011

In Millions, unless otherwise specified

Letter of Credit

Revolving Credit Facility

Revolving Credit Facility

Risk Sharing Finance Facility Agreement [Member]

Risk Sharing Finance Facility Agreement [Member]

Senior Notes

Senior Notes Due 2016, 3.550%

Senior Notes Due 2016, 3.550%

Senior Notes Due 2016, 3.550%

Senior Notes Due 2021, 4.875%

Senior Notes Due 2021, 4.875%

Senior Notes Due 2021, 4.875%

USD ($)

USD ($)

USD ($)

EUR (€)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Credit Facilities and Long-Term Debt [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

Fair value of senior notes due

'

'

'

'

'

'

$633

$635

'

$639

$629

'

Interest on notes due

'

'

'

'

'

'

'

'

3.55%

'

'

4.88%

Long-term Debt, Gross

'

'

'

'

'

'

600

600

600

600

600

600

Redemption price percentage

'

'

'

'

'

101.00%

'

'

'

'

'

'

Debt instrument aggregate principal amount

100

'

600

165

120

'

'

'

'

'

'

'

Interest rate per annum, effective rate

'

1.00%

'

'

'

'

'

'

'

'

'

'

Maximum leverage ratio

'

3.5

'

3.5

'

'

'

'

'

'

'

'

Line of Credit Facility, Amount Outstanding

'

'

'

$39

'

'

'

'

'

'

'

'

Postretirement_Benefit_Plans_D

Postretirement Benefit Plans (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Net periodic benefit cost:	'	'
Amortization of net actuarial loss	$1	$1
Net periodic benefit cost	6	7
Domestic defined benefit pension plans	'	'
Net periodic benefit cost:	'	'
Service cost	0	1
Interest cost	1	1
Expected return on plan assets	-1	-1
Net periodic benefit cost	1	2
International defined benefit pension plans	'	'
Net periodic benefit cost:	'	'
Service cost	4	3
Interest cost	7	7
Expected return on plan assets	-8	-8
Amortization of net actuarial loss	2	3
Net periodic benefit cost	$5	$5

Postretirement_Benefit_Plans_D1

Postretirement Benefit Plans (Details Textual) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block	'	'
Other Postretirement Benefit Expense	$1	$1
Postretirement Benefit Plans (Textual) [Abstract]	'	'
Employer Contribution to definer benefit Plan	'	11
Minimum	'	'
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block	'	'
Additional contributions	30	'
Maximum	'	'
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block	'	'
Additional contributions	$40	'

StockBased_Compensation_Plans_1

Stock-Based Compensation Plans (Details) (Restricted Stock [Member], USD $)	3 Months Ended
	Mar. 31, 2014
Restricted Stock [Member]	'
Summary of restricted stock activity	'
Outstanding Shares at December 31, 2012 (in shares)	1,275,000
Restricted Stock, Granted (in shares)	286,000
Restricted Stock, Vested (in shares)	-182,000
Restricted Stock, Forfeited (in shares)	-24,000
Outstanding Shares at June 30, 2013 (in shares)	1,355,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]	'
Weighted Average Grant Date Fair Value, Outstanding at December 31, 2012 (usd per share)	$27.67
Weighted Average Grant Date Fair Value, Granted (usd per share)	$38.74
Weighted Average Grant Date Fair Value, Vested (usd per share)	$32.06
Weighted Average Grant Date Fair Value, Forfeited (usd per share)	$27.45
Weighted Average Grant Date Fair Value, Outstanding at June 30, 2013 (usd per share)	$29.45

StockBased_Compensation_Plans_2

Stock-Based Compensation Plans (Details 1) (USD $)	3 Months Ended	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Summary of the changes in outstanding stock options	'	'
Stock Options Outstanding at January 1, 2014 (in shares)	3,504	'
Stock options, Granted (in shares)	373	'
Stock options, Exercised (in shares)	-386	'
Stock options, Forfeited (in shares)	-37	'
Stock Options Outstanding at March 31, 2014 (in shares)	3,454	3,504
Options exercisable at March 31, 2014 (in shares)	2,131	'
Vested and expected to vest as of March 31, 2014 (in shares)	3,339	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]	'	'
Weighted Average Exercise Price, Outstanding at January 1, 2014 (usd per share)	$26.80	'
Weighted Average Exercise Price / Share, Granted (usd per share)	$38.76	'
Weighted Average Exercise Price / Share, Exercised (usd per share)	$27.82	'
Weighted Average Exercise Price / Share, Forfeited (usd per share)	$23.40	'
Weighted Average Exercise Price, Outstanding at March 31, 2014 (usd per share)	$28.01	$26.80
Options exercisable, Weighted Average Exercise Price (usd per share)	$26.98	'
Vested and expected to vest as of March 31, 2014 (usd per share)	$27.81	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Roll Forward]	'	'
Weighted Average Remaining Contractual Term, Outstanding at January 1, 2014	'7 years	'6 years 4 months 24 days
Weighted Average Remaining Contractual Term, Options Granted	'10 years	'
Weighted Average Remaining Contractual Term, Options Exercised	'2 years 9 months 18 days	'
Weighted Average Remaining Contractual Term, Options Forfeited	'4 years	'
Weighted Average Remaining Contractual Term, Outstanding at March 31, 2014	'7 years	'6 years 4 months 24 days
Weighed average remaining contractual term, Options exercisable	'6 years	'
Vested and expected to vest as of March 31, 2014	'6 years 10 months 24 days	'

StockBased_Compensation_Plans_3

Stock-Based Compensation Plans Share-Based Compensation Plan (Details 2) (Performance Based Shares, USD $)	3 Months Ended
	Mar. 31, 2014
Performance Based Shares	'
Summary of performance share activity	'
Outstanding Shares at December 31, 2012 (in shares)	52,000
Restricted Stock, Granted (in shares)	43,000
Restricted Stock, Vested (in shares)	0
Restricted Stock, Forfeited (in shares)	0
Outstanding Shares at June 30, 2013 (in shares)	95,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]	'
Weighted Average Grant Date Fair Value, Outstanding at December 31, 2012 (usd per share)	$27.49
Weighted Average Grant Date Fair Value, Granted (usd per share)	$38.76
Weighted Average Grant Date Fair Value, Vested (usd per share)	$0
Weighted Average Grant Date Fair Value, Forfeited (usd per share)	$0
Weighted Average Grant Date Fair Value, Outstanding at June 30, 2013 (usd per share)	$32.54

StockBased_Compensation_Plans_4

Stock-Based Compensation Plans Share-Based Compensation Plans (Details 3) (Stock Options, USD $)	3 Months Ended
	Mar. 31, 2014
Stock Options	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Dividend yield	1.32%
Volatility	28.80%
Risk-free interest rate	1.79%
Expected term (in years)	'5 years 8 months 12 days
Weighted-average fair value / share	$9.99

StockBased_Compensation_Plans_5

Stock-Based Compensation Plans (Details Textual) (USD $)	3 Months Ended					0 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 17, 2014	Mar. 17, 2014	Mar. 17, 2014
			Stock Options	Restricted Stock	Performance Based Shares	Patrick Decker	Patrick Decker	Patrick Decker
							Restricted Stock	Performance Based Shares
Share-based Compensation Arrangement by Share-based Payment Award	'	'	'	'	'	'	'	'
Share-based compensation	$4,000,000	$6,000,000	'	'	'	'	'	'
Unamortized compensation expense	'	'	8,000,000	23,000,000	3,000,000	'	'	'
Weighted average period	'	'	'2 years	'2 years 1 month 6 days	'2 years 6 months	'	'	'
Shares Awarded	373,000	'	'	'	'	165,584	'	'
Shares Awarded	'	'	'	286,000	43,000	'	40,342	40,342
Stock-Based Compensation Plans (Textual) [Abstract]	'	'	'	'	'	'	'	'
Amount of cash received from the exercise of stock options	11,000,000	1,000,000	'	'	'	'	'	'
Aggregate intrinsic value of outstanding stock options	20,000,000	'	'	'	'	'	'	'
Aggregate intrinsic value of exercisable stock options	30,000,000	'	'	'	'	'	'	'
Aggregate intrinsic value of vested and expected to vest stock options	29,000,000	'	'	'	'	'	'	'
Total intrinsic value of options exercised	$4,000,000	'	'	'	'	'	'	'

Capital_Stock_Details

Capital Stock (Details) (USD $)	3 Months Ended		0 Months Ended	3 Months Ended	0 Months Ended	3 Months Ended
In Millions, except Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Aug. 20, 2013	Mar. 31, 2014	Aug. 18, 2012	Mar. 31, 2014	Mar. 31, 2013
			2013 Stock Repurchase Program	2013 Stock Repurchase Program	2012 Stock Repurchase Program	2012 Stock Repurchase Program	2012 Stock Repurchase Program
Equity, Class of Treasury Stock [Line Items]	'	'	'	'	'	'	'
Stock repurchase program, authorized amount	'	'	$250	'	$2	'	'
Shares repurchased (in shares)	100,000	100,000	'	1,300,000	'	0	500,000
Shares repurchased (in dollars)	1	1	'	50	'	'	14
Stock repurchase program, remaining authorized repurchase amount	'	'	'	$150	'	'	'
Stock repurchase program, remaining number of shares authorized to be repurchased	'	'	'	'	'	1,000,000	'

Accumulated_Other_Comprehensiv2

Accumulated Other Comprehensive Income (Loss) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014
Accumulated Other Comprehensive Income (Loss) [Roll Forward]	'
Beginning balance	$167
Foreign currency translation adjustment	-2
Income tax expense on amortization of postretirement benefit plan items	-1
Reclassification of unrealized gain (loss) on foreign exchange agreements	-1
Ending balance	166
Foreign Currency Translation	'
Accumulated Other Comprehensive Income (Loss) [Roll Forward]	'
Beginning balance	351
Foreign currency translation adjustment	-2
Income tax expense on amortization of postretirement benefit plan items	0
Reclassification of unrealized gain (loss) on foreign exchange agreements	0
Ending balance	349
Postretirement Benefit Plans	'
Accumulated Other Comprehensive Income (Loss) [Roll Forward]	'
Beginning balance	-186
Foreign currency translation adjustment	0
Income tax expense on amortization of postretirement benefit plan items	-1
Reclassification of unrealized gain (loss) on foreign exchange agreements	0
Ending balance	-184
Derivative Instruments	'
Accumulated Other Comprehensive Income (Loss) [Roll Forward]	'
Beginning balance	2
Foreign currency translation adjustment	0
Income tax expense on amortization of postretirement benefit plan items	0
Reclassification of unrealized gain (loss) on foreign exchange agreements	-1
Ending balance	1
Cost of revenue	'
Accumulated Other Comprehensive Income (Loss) [Roll Forward]	'
Amortization of net actuarial loss on postretirement benefit plans into:	1
Reclassification of unrealized gain (loss) on foreign exchange agreements	1
Cost of revenue | Foreign Currency Translation	'
Accumulated Other Comprehensive Income (Loss) [Roll Forward]	'
Amortization of net actuarial loss on postretirement benefit plans into:	0
Reclassification of unrealized gain (loss) on foreign exchange agreements	0
Cost of revenue | Postretirement Benefit Plans	'
Accumulated Other Comprehensive Income (Loss) [Roll Forward]	'
Amortization of net actuarial loss on postretirement benefit plans into:	1
Reclassification of unrealized gain (loss) on foreign exchange agreements	0
Cost of revenue | Derivative Instruments	'
Accumulated Other Comprehensive Income (Loss) [Roll Forward]	'
Amortization of net actuarial loss on postretirement benefit plans into:	0
Reclassification of unrealized gain (loss) on foreign exchange agreements	1
Selling, general and administrative expenses	'
Accumulated Other Comprehensive Income (Loss) [Roll Forward]	'
Amortization of net actuarial loss on postretirement benefit plans into:	2
Selling, general and administrative expenses | Foreign Currency Translation	'
Accumulated Other Comprehensive Income (Loss) [Roll Forward]	'
Amortization of net actuarial loss on postretirement benefit plans into:	0
Selling, general and administrative expenses | Postretirement Benefit Plans	'
Accumulated Other Comprehensive Income (Loss) [Roll Forward]	'
Amortization of net actuarial loss on postretirement benefit plans into:	2
Selling, general and administrative expenses | Derivative Instruments	'
Accumulated Other Comprehensive Income (Loss) [Roll Forward]	'
Amortization of net actuarial loss on postretirement benefit plans into:	0
Revenue	'
Accumulated Other Comprehensive Income (Loss) [Roll Forward]	'
Reclassification of unrealized gain (loss) on foreign exchange agreements	1
Revenue | Foreign Currency Translation	'
Accumulated Other Comprehensive Income (Loss) [Roll Forward]	'
Reclassification of unrealized gain (loss) on foreign exchange agreements	0
Revenue | Postretirement Benefit Plans	'
Accumulated Other Comprehensive Income (Loss) [Roll Forward]	'
Reclassification of unrealized gain (loss) on foreign exchange agreements	0
Revenue | Derivative Instruments	'
Accumulated Other Comprehensive Income (Loss) [Roll Forward]	'
Reclassification of unrealized gain (loss) on foreign exchange agreements	$1

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Warranties	'	'
Warranty accrual - January 1	$37	$40
Net changes for product warranties in the period	5	8
Settlement of warranty claims	-8	-8
Warranty accrual - March 31	$34	$40

Commitments_and_Contingencies_2

Commitments and Contingencies (Details Textual) (USD $)	3 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'	'
Accrual for legal matters	$17	$17
Estimated environmental matters	7	8
Estimated losses in excess of accruals	$29	$26

Segment_Information_Details

Segment Information (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Financial information for each reportable segment	'	'
Revenue	$906	$879
Operating income	76	66
Depreciation and amortization	36	37
Capital expenditures	25	30
Water Infrastructure	'	'
Financial information for each reportable segment	'	'
Revenue	568	551
Operating income	46	42
Depreciation and amortization	27	28
Capital expenditures	14	18
Applied Water	'	'
Financial information for each reportable segment	'	'
Revenue	355	345
Operating income	41	40
Depreciation and amortization	7	8
Capital expenditures	8	11
Eliminations	'	'
Financial information for each reportable segment	'	'
Revenue	-17	-17
Corporate and other	'	'
Financial information for each reportable segment	'	'
Operating income	-11	-16
Depreciation and amortization	2	1
Capital expenditures	$3	$1

Segment_Information_Details_1

Segment Information (Details 1) (USD $)	Mar. 31, 2014		Dec. 31, 2013
In Millions, unless otherwise specified
Total assets for each reportable segment	'		'
Total assets	$4,887		$4,896
Water Infrastructure	'		'
Total assets for each reportable segment	'		'
Total assets	2,986		2,989
Applied Water	'		'
Total assets for each reportable segment	'		'
Total assets	1,379		1,340
Corporate and other	'		'
Total assets for each reportable segment	'		'
Total assets	$522	[1]	$567	[1]
[1]	Corporate and other consists of items pertaining to our corporate headquarters function, which principally consist of cash, deferred tax assets, pension assets and certain property, plant and equipment.

Segment_Information_Details_Te

Segment Information (Details Textual)	3 Months Ended
	Mar. 31, 2014
	Segment
Segment Information (Textual) [Abstract]	'
Number of reportable segments	2